Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 192 | 212 | 3 | 1 | 3 |
| Cost of Goods | 13 | 2 | 182 | 1 | 2 |
| Gross Profit | 178 | 211 | -179 | 0 | 1 |
| Operating Expenses | 681 | 943 | 1,193 | 397 | 528 |
| Operating Income | -489 | -731 | -1,190 | -396 | -524 |
| Interest Expense | 133 | 130 | 117 | 122 | 117 |
| Other Income | -34 | -70 | -2,746 | -238 | -172 |
| Pre-tax Income | -655 | -931 | -4,052 | -756 | -813 |
| Income Tax | -41 | -58 | -125 | -69 | -77 |
| Net Income Continuous | -615 | -873 | -3,928 | -687 | -736 |
| Minority Interests | -57 | -82 | -157 | -117 | -104 |
| Net Income | $-558 | $-792 | $-3,771 | $-571 | $-632 |
| EPS Basic Total Ops | -0.30 | -0.50 | -3.20 | -0.60 | -0.50 |
| EPS Basic Continuous Ops | -0.35 | -0.58 | -3.40 | -0.58 | -0.63 |
| EPS Diluted Total Ops | -0.30 | -0.50 | -3.20 | -0.60 | -0.50 |
| EPS Diluted Continuous Ops | -0.35 | -0.58 | -3.40 | -0.58 | -0.63 |
| EBITDA(a) | $-473 | $-717 | $-1,179 | $-386 | $-513 |